Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_31212 | 97 | 2.02 | Mlig455_028599, Mlig455_056911 | Neo: - Age: - |
Mlig455_028599 {REF} {Length: 600} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362} Mlig455_056911 {REF} {Length: 602} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -3.739 | 1.823 | 0.49993 | 1.00000 | |
RegionR2 | 2.471 | 1.823 | 0.03873 | 0.22843 | |
RegionR3 | -0.242 | 1.823 | 0.91689 | 1.00000 | |
RegionR4 | -0.714 | 1.823 | 0.97640 | 1.00000 | |
RegionR5 | -2.009 | 1.823 | 0.99919 | 1.00000 | |
RegionR6 | 0.594 | 1.823 | 0.57862 | 1.00000 | |
RegionR7 | 1.344 | 1.823 | 0.27700 | 0.90847 | |
RegionR8 | 2.295 | 1.823 | 0.08067 | 0.53894 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.479 | 1.823 | 0.99998 | 1.00000 | |
RegenerationR2 | -0.54 | 1.823 | 0.48306 | 0.86452 | |
RegenerationR3 | 1.005 | 1.823 | 0.31982 | 0.74828 | |
RegenerationR4 | -0.199 | 1.823 | 0.85492 | 1.00000 | |
RegenerationR5 | 1.605 | 1.823 | 0.10822 | 0.49766 | |
RegenerationR6 | -4.415 | 1.823 | 0.00491 | 0.08485 | |
RegenerationBL | -4.758 | 1.823 | 0.04903 | 0.25444 | |
RegenerationTP | -0.449 | 1.823 | 0.70544 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_31212 | 97 | 2.02 | Mlig455_028599, Mlig455_056911 | Neo: - Age: - |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_028599 {REF} {Length: 600} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362} Mlig455_056911 {REF} {Length: 602} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362} |
|
2. | MligTC455_31210 | 51 | 1.07 | Mlig455_028581 | Neo: - Age: Down-Up-Down |
KCNH7 | 4.96 | 1.000 | 0.998 | 0.995 | - | 0.982 | 0.985 | Mlig455_028581 {REF} {Length: 6310} {Pfam: Ion transport protein [PF00520.33, score=119.1]; PAS domain [PF13426.9, score=52.9]; Ion channel [PF07885.18, score=45.3]; Cyclic nucleotide-binding domain [PF00027.31, score=45.2]; PAS fold [PF00989.27, score=31.5]; PAS fold [PF08447.14, score=26.5]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=820, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=810, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=808, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=820, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=808, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=806, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=766, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=746, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=793, Expect=0.0]} {RNA1509_40124} {RNA1310_20497} {RNA815_15478} |
3. | MligTC455_29510 | 1443 | 30.06 | Mlig455_003367, Mlig455_003369 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.360 Region-enriched R8: 1.897/0.00063 Regeneration-downregulated BL: -2.492 Regeneration-depleted BL: -2.492 |
3.282 | - | 0.964 | 0.799 | 0.783 | - | 0.736 | Mlig455_003367 {REF} {Length: 1906} {Pfam: Interferon-induced 6-16 family [PF06140.15, score=25.4]} {RNA1509_46297} {RNA1310_31671} {RNA815_28401} Mlig455_003369 {REF} {Length: 1024} {RNA1509_28087, RNA1509_46297} {RNA1310_31671, RNA1509_28087, RNA1509_46297} {RNA1509_28087, RNA1509_46297, RNA815_17641.1} |
|
4. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 2.705 | - | - | 0.852 | 0.901 | 0.952 | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
5. | MligTC455_14604 | 21 | 0.43 | Mlig455_014269 | Neo: - Age: - |
2.627 | - | - | 0.786 | 0.870 | 0.971 | - | Mlig455_014269 {REF} {Length: 2720} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=90.5]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=53.1, Expect=2e-07]} {Smed: dd_Smed_v6_14355_0_1, dd_Smed_v6_14355_0_1, [Score=108, Expect=3e-25]} {RNA1310_19428.1} {RNA815_22602} | |
6. | MligTC455_47244 | 216 | 4.49 | Mlig455_016130 | Neo: - Age: - Region-enriched R2: 3.391/0.02151 |
2.582 | 0.858 | - | 0.768 | - | 0.956 | - | Mlig455_016130 {REF} {Length: 3312} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=27.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=20.5]} {Smed: dd_Smed_v6_24733_0_1, dd_Smed_v6_24733_0_1, [RH, Score=231, Expect=1e-71]} {RNA1509_41111} {RNA1310_18481.1} {RNA815_10445} | |
7. | MligTC455_13130 | 40 | 0.83 | Mlig455_032511, Mlig455_068691 | Neo: - Age: - |
WSCD2 | 2.468 | - | - | 0.776 | 0.713 | 0.979 | - | Mlig455_032511 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=40.9]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.4, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {RNA1310_39527} {RNA815_19067} Mlig455_068691 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=41.8]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.1, Expect=1e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=49.7, Expect=9e-07]; ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=4e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=62.0, Expect=6e-11]} {RNA1310_39527} {RNA815_19067} |
8. | MligTC455_13471 | 12 | 0.26 | Mlig455_065390 | Neo: - Age: - |
1.819 | - | - | 0.849 | - | 0.970 | - | Mlig455_065390 {REF} {Length: 665} {NoTransDecoderORF} {RNA1509_16969} {RNA1310_51432} {RNA815_47685} | |
9. | MligTC455_53722 | 292 | 6.08 | Mlig455_025654 | Neo: - Age: - |
1.815 | - | 0.973 | - | - | 0.842 | - | Mlig455_025654 {REF} {Length: 1239} {Pfam: Sel1 repeat [PF08238.14, score=31.9]} {Smed: dd_Smed_v6_9387_0_1, dd_Smed_v6_9387_0_1, [RH, Score=194, Expect=2e-62]} {RNA1509_19616} {RNA1310_29567, RNA1509_19616} {RNA1509_19616, RNA815_13742} | |
10. | MligTC455_19171 | 162 | 3.38 | Mlig455_047844 | Neo: - Age: - |
LRRD1 | 1.813 | - | - | - | 0.844 | 0.969 | - | Mlig455_047844 {REF} {Length: 3483} {Pfam: Leucine rich repeat [PF13855.8, score=200.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=161.9]; Leucine-rich repeat [PF14580.8, score=62.9]; Death domain [PF00531.24, score=25.2]; RsmF rRNA methyltransferase first C-terminal domain [PF17126.7, score=19.3]} {Human: ENSG00000240720, LRRD1, leucine rich repeats and death domain containing 1, [RH, Score=265, Expect=2e-76]} {Mouse: ENSMUSG00000040367, Lrrd1, leucine rich repeats and death domain containing 1, [RH, Score=305, Expect=1e-91]} {Dmel: FBgn0038504, Sur-8, [Score=157, Expect=3e-40]} {Celegans: WBGene00004929, soc-2, Leucine-rich repeat protein soc-2, [Score=151, Expect=1e-38]} {Smed: dd_Smed_v6_10136_0_1, dd_Smed_v6_10136_0_1, [RH, Score=281, Expect=6e-85]} {RNA1509_11343, RNA1509_19633} {RNA1310_7039.2, RNA1509_11343} {RNA1509_11343, RNA815_1369.1} |
11. | MligTC455_44444 | 123 | 2.57 | Mlig455_062758 | Neo: - Age: - |
1.805 | 0.834 | - | - | - | 0.971 | - | Mlig455_062758 {REF} {Length: 1304} {Pfam: Retinal tissue protein [PF10044.11, score=28.1]} {RNA1509_3524} {RNA1310_10649.1} {RNA815_4708.1} | |
12. | MligTC455_40226 | 43 | 0.89 | Mlig455_010646, Mlig455_010651 | Neo: - Age: - |
GRIK2 | 1.794 | - | - | 0.843 | - | - | 0.951 | Mlig455_010646 {REF} {Length: 1094} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.3]; LIM domain [PF00412.24, score=31.8]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=137, Expect=3e-32]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=135, Expect=8e-32]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=133, Expect=6e-31]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=136, Expect=4e-32]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=135, Expect=7e-32]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=134, Expect=2e-31]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=278, Expect=1e-79]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=254, Expect=2e-74]} {Smed: dd_Smed_v6_5330_0_1, dd_Smed_v6_5330_0_1, [Score=196, Expect=5e-51]} {RNA1310_59687} {RNA815_48326} Mlig455_010651 {REF} {Length: 3614} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.3]; LIM domain [PF00412.24, score=31.8]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=137, Expect=3e-32]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=135, Expect=8e-32]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=133, Expect=6e-31]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=136, Expect=4e-32]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=135, Expect=7e-32]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=134, Expect=2e-31]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=278, Expect=1e-79]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=254, Expect=2e-74]} {Smed: dd_Smed_v6_5330_0_1, dd_Smed_v6_5330_0_1, [Score=196, Expect=5e-51]} {RNA1509_35609} {RNA1310_6947.1} {RNA815_20684} |
13. | MligTC455_19695 | 59 | 1.23 | Mlig455_067848 | Neo: - Age: logFC(26M/2M)=-0.595 |
1.769 | - | - | - | - | 0.959 | 0.810 | Mlig455_067848 {REF} {Length: 1979} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=32.9]} {Smed: dd_Smed_v6_12148_0_3, dd_Smed_v6_12148_0_3, [Score=76.3, Expect=8e-16]} {RNA1509_37281} {RNA1310_6533.1} {RNA815_6407} | |
14. | MligTC455_24515 | 14 | 0.28 | Mlig455_033346, Mlig455_033365 | Neo: - Age: - |
HTR1B | 1.762 | - | - | 0.799 | - | 0.963 | - | Mlig455_033346 {REF} {Length: 1493} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.5]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=4e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=189, Expect=2e-54]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=176, Expect=4e-50]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=218, Expect=5e-66]} {RNA1310_132724} Mlig455_033365 {REF} {Length: 1935} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=24.0]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=7e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=191, Expect=4e-55]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=178, Expect=8e-51]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=216, Expect=2e-65]} {RNA1310_132724} |
15. | MligTC455_51200 | 66 | 1.37 | Mlig455_057090 | Neo: - Age: - |
1.753 | 0.789 | - | - | - | 0.964 | - | Mlig455_057090 {REF} {Length: 988} {RNA1310_63663} {RNA815_36272} | |
16. | MligTC455_41694 | 404 | 8.41 | Mlig455_026434, Mlig455_026464 | Neo: - Age: - |
SSUH2 | 1.748 | - | - | - | 0.786 | 0.962 | - | Mlig455_026434 {REF} {Length: 1709} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=210, Expect=4e-64]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=177, Expect=5e-52]} {RNA1509_35286} {RNA1310_19837, RNA1509_35286} {RNA1509_35286, RNA815_11262} Mlig455_026464 {REF} {Length: 1584} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=210, Expect=7e-64]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=178, Expect=4e-52]} {RNA1509_35286} {RNA1310_19837} {RNA815_11262} |
17. | MligTC455_54226 | 52 | 1.09 | Mlig455_037435, Mlig455_037458 | Neo: - Age: - |
NETO2 | 1.734 | - | - | - | 0.740 | 0.994 | - | Mlig455_037435 {REF} {Length: 2663} {Pfam: CUB domain [PF00431.22, score=52.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=96.3, Expect=3e-20]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [Score=97.8, Expect=6e-21]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=87.8, Expect=1e-17]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=77.4, Expect=4e-15]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=87.0, Expect=1e-17]} {RNA1310_38111} Mlig455_037458 {REF} {Length: 2349} {Pfam: CUB domain [PF00431.22, score=52.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [RH, Score=144, Expect=9e-37]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [RH, Score=146, Expect=1e-37]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=117, Expect=2e-27]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=105, Expect=1e-24]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=115, Expect=6e-27]} {RNA1310_38111} |
18. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 1.728 | - | - | - | 0.745 | 0.983 | - | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
19. | MligTC455_49878 | 31 | 0.65 | Mlig455_050656 | Neo: - Age: - |
CHRNA10 | 1.722 | - | - | 0.737 | - | 0.985 | - | Mlig455_050656 {REF} {Length: 1810} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=89.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.7]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=145, Expect=8e-38]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=7e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=4e-37]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=9e-37]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=143, Expect=9e-38]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=7e-37]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=139, Expect=4e-36]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=134, Expect=3e-34]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=126, Expect=9e-32]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=133, Expect=3e-34]} {RNA1310_26175} {RNA815_7952} |
20. | MligTC455_15324 | 212 | 4.42 | Mlig455_018628 | Neo: - Age: - |
CAPN7 | 1.697 | - | - | 0.974 | 0.723 | - | - | Mlig455_018628 {REF} {Length: 2837} {TRANSSPLICED} {Pfam: Calpain family cysteine protease [PF00648.23, score=151.6]; Calpain large subunit, domain III [PF01067.24, score=65.5]; MIT (microtubule interacting and transport) domain [PF04212.20, score=58.0]} {Human: ENSG00000131375, CAPN7, calpain 7, [RH, Score=818, Expect=0.0]} {Mouse: ENSMUSG00000021893, Capn7, calpain 7, [RH, Score=830, Expect=0.0]} {Dmel: FBgn0003464, sol, small optic lobes, [Score=121, Expect=1e-27]} {Celegans: WBGene00000543, clp-2, CaLPain family, [RH, Score=621, Expect=0.0]} {Smed: dd_Smed_v6_6402_0_1, dd_Smed_v6_6402_0_1, [RH, Score=812, Expect=0.0]} {RNA1509_9441} {RNA1310_7284} {RNA815_5790} |
21. | MligTC455_11494 | 99 | 2.06 | Mlig455_055605 | Neo: - Age: Down-Up-Down |
HS3ST5 | 1.695 | - | - | - | 0.745 | 0.950 | - | Mlig455_055605 {REF} {Length: 2196} {Pfam: Sulfotransferase domain [PF00685.29, score=91.7]; Sulfotransferase family [PF13469.8, score=45.8]} {Human: ENSG00000249853, HS3ST5, heparan sulfate-glucosamine 3-sulfotransferase 5, [RH, Score=256, Expect=1e-82]} {Mouse: ENSMUSG00000044499, Hs3st5, heparan sulfate (glucosamine) 3-O-sulfotransferase 5, [RH, Score=257, Expect=2e-83]} {Dmel: FBgn0031005, Hs3st-B, Heparan sulfate 3-O sulfotransferase-B, [Score=205, Expect=9e-63]} {Celegans: WBGene00044303, hst-3.2, Heparan SulphoTransferase, [Score=215, Expect=7e-68]} {Smed: dd_Smed_v6_81402_0_1, dd_Smed_v6_81402_0_1, [Score=123, Expect=7e-34]} {RNA1310_37118} {RNA815_58609} |
22. | MligTC455_19888 | 22 | 0.46 | Mlig455_066525 | Neo: - Age: - |
AC254952.1 | 1.689 | - | - | - | 0.736 | 0.953 | - | Mlig455_066525 {REF} {Length: 1890} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=188.2]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=20.4]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=188, Expect=5e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=185, Expect=4e-56]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=195, Expect=4e-58]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=242, Expect=1e-75]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=175, Expect=7e-51]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=228, Expect=9e-71]} {RNA1310_34222.1} {RNA815_33884} |
23. | MligTC455_22841 | 20 | 0.41 | Mlig455_066350 | Neo: - Age: - |
1.685 | - | - | 0.724 | - | 0.961 | - | Mlig455_066350 {REF} {Length: 694} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_35987, RNA1509_46319} {RNA1310_35806, RNA1509_35987, RNA1509_46319} {RNA1509_35987, RNA1509_46319, RNA815_14596} | |
24. | MligTC455_43324 | 71 | 1.47 | Mlig455_041984 | Neo: - Age: - Region-enriched R2: 6.623/0.00573 |
1.681 | - | - | - | 0.731 | 0.950 | - | Mlig455_041984 {REF} {Length: 388} {NoTransDecoderORF} {RNA1509_49821} {RNA1310_52560.2} {RNA815_59873} | |
25. | MligTC455_48125 | 91 | 1.9 | Mlig455_005602, Mlig455_070397 | Neo: - Age: - Region-enriched R2: 4.171/0.01740 |
1.678 | - | - | 0.707 | - | 0.971 | - | Mlig455_005602 {REF} {Length: 2407} {RNA1509_6760} {RNA1310_2628} {RNA815_4402} Mlig455_070397 {REF} {Length: 2447} {RNA1509_6760} {RNA1310_132399} {RNA815_4402} |
|
26. | MligTC455_31879 | 41 | 0.85 | Mlig455_035930 | Neo: - Age: - |
1.673 | - | - | - | - | 0.954 | 0.719 | Mlig455_035930 {REF} {Length: 1472} {Pfam: Bacterial transferase hexapeptide (six repeats) [PF00132.26, score=21.3]} {RNA1509_54816} {RNA1310_46323, RNA1509_54816} {RNA1509_54816, RNA815_13104.1} | |
27. | MligTC455_43525 | 62 | 1.29 | Mlig455_041078 | Neo: - Age: - |
1.672 | - | - | - | 0.722 | 0.950 | - | Mlig455_041078 {REF} {Length: 3896} {RNA1509_39963} {RNA1310_38466} {RNA815_23614} | |
28. | MligTC455_20379 | 17 | 0.36 | Mlig455_013410 | Neo: - Age: - Region-enriched R2: 6.911/0.01361 |
PLSCR2 | 1.657 | - | - | 0.707 | - | 0.950 | - | Mlig455_013410 {REF} {Length: 1971} {Pfam: Scramblase [PF03803.17, score=92.3]} {Human: ENSG00000163746, PLSCR2, phospholipid scramblase 2, [Score=77.8, Expect=2e-15]; ENSG00000114698, PLSCR4, phospholipid scramblase 4, [Score=77.0, Expect=5e-15]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=84.3, Expect=1e-17]} {Celegans: WBGene00011935, scrm-1, Phospholipid scramblase, [Score=89.7, Expect=6e-20]} {RNA1310_32034} {RNA815_51815} |
29. | MligTC455_43791 | 1365 | 28.43 | Mlig455_044501 | Neo: - Age: logFC(26M/2M)=-0.753 Region-enriched R2: 1.262/0.02262 |
CAPSL | 1.653 | - | - | 0.703 | - | 0.950 | - | Mlig455_044501 {REF} {Length: 1977} {TRANSSPLICED} {Pfam: EF-hand domain [PF13405.8, score=66.4]; EF-hand domain pair [PF13499.8, score=64.1]; EF hand [PF00036.34, score=59.3]; EF hand [PF13202.8, score=45.3]; EF-hand domain pair [PF13833.8, score=40.6]} {Human: ENSG00000152611, CAPSL, calcyphosine like, [RH, Score=271, Expect=8e-93]} {Mouse: ENSMUSG00000039676, Capsl, calcyphosine-like, [RH, Score=280, Expect=2e-96]} {Dmel: FBgn0051345, CG31345, [RH, Score=244, Expect=1e-82]} {Celegans: WBGene00019770, M04F3.4, [Score=50.4, Expect=6e-08]} {Smed: dd_Smed_v6_4512_0_1, dd_Smed_v6_4512_0_1, [RH, Score=290, Expect=1e-100]} {RNA1509_16154, RNA1509_16210, RNA1509_5158} {RNA1310_25986.1, RNA1509_16154, RNA1509_16210, RNA1509_5158} {RNA1509_16154, RNA1509_16210, RNA1509_5158, RNA815_11323} |
30. | MligTC455_50029 | 35 | 0.74 | Mlig455_010619, Mlig455_010708 | Neo: - Age: - |
FOXA1 | 0.995 | - | - | - | - | 0.995 | - | Mlig455_010619 {REF} {Length: 1170} {Pfam: Forkhead domain [PF00250.20, score=110.8]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000170608, FOXA3, forkhead box A3, [Score=164, Expect=1e-47]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=3e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=164, Expect=7e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=7e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=169, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=150, Expect=3e-42]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=175, Expect=2e-51]} Mlig455_010708 {REF} {Length: 1194} {Pfam: Forkhead domain [PF00250.20, score=110.9]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]; ENSG00000170608, FOXA3, forkhead box A3, [Score=163, Expect=1e-47]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=4e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=165, Expect=2e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=9e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=168, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=151, Expect=2e-42]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=175, Expect=2e-51]} |
31. | MligTC455_53285 | 6 | 0.13 | Mlig455_061305 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_061305 {REF} {Length: 422} {NoTransDecoderORF} | |
32. | MligTC455_23922 | 8 | 0.17 | Mlig455_001765 | Neo: - Age: Down-Up-Down |
0.994 | - | - | - | - | 0.994 | - | Mlig455_001765 {REF} {Length: 4721} {Pfam: AMP-binding enzyme [PF00501.30, score=68.9]} {RNA1509_37800} {RNA1310_40483} {RNA815_30709} | |
33. | MligTC455_09686 | 4 | 0.08 | Mlig455_061629 | Neo: - Age: - |
0.993 | - | - | - | - | 0.993 | - | Mlig455_061629 {REF} {Length: 1698} {NoTransDecoderORF} {RNA1509_20320} {RNA1310_104302} {RNA815_52785.1} | |
34. | MligTC455_14578 | 33 | 0.69 | Mlig455_033066 | Neo: - Age: - |
0.993 | - | - | - | - | 0.993 | - | Mlig455_033066 {REF} {Length: 2292} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=137.2]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=63.9, Expect=1e-10]} {RNA1310_28762} {RNA815_42177} | |
35. | MligTC455_02461 | 5 | 0.11 | Mlig455_019900 | Neo: - Age: - |
0.992 | - | - | - | - | 0.992 | - | Mlig455_019900 {REF} {Length: 253} {NoTransDecoderORF} {RNA1509_34377} {RNA1310_100135} | |
36. | MligTC455_05979 | 11 | 0.23 | Mlig455_067718 | Neo: - Age: - |
0.989 | - | - | - | - | 0.989 | - | Mlig455_067718 {REF} {Length: 1018} {RNA1509_2330} {RNA1310_37520} {RNA815_22367} | |
37. | MligTC455_06577 | 7 | 0.14 | Mlig455_044334 | Neo: - Age: Up-Down-Down |
0.987 | - | - | - | - | 0.987 | - | Mlig455_044334 {REF} {Length: 706} | |
38. | MligTC455_22853 | 33 | 0.7 | Mlig455_019405, Mlig455_059068 | Neo: - Age: - |
0.987 | - | - | - | - | 0.987 | - | Mlig455_019405 {REF} {Length: 4200} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=66.2, Expect=9e-12]} {RNA1310_63811} Mlig455_059068 {REF} {Length: 4200} {Pfam: Integrase zinc binding domain [PF17921.3, score=58.4]; Integrase core domain [PF00665.28, score=32.8]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=63.5, Expect=1e-10]} {RNA1310_63811} |
|
39. | MligTC455_30594 | 23 | 0.48 | Mlig455_038529, Mlig455_052221 | Neo: - Age: - |
0.986 | - | - | - | - | 0.986 | - | Mlig455_038529 {REF} {Length: 805} {Pfam: Lecithin retinol acyltransferase [PF04970.15, score=35.1]} {RNA1509_40834} {RNA1310_11051} {RNA815_3523.1} Mlig455_052221 {REF} {Length: 7356} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=40.2]; Mab-21 protein [PF03281.16, score=18.9]} {RNA1509_14346, RNA1509_40834} {RNA1310_11051, RNA1509_14346} {RNA1509_14346, RNA815_3523.1} |
|
40. | MligTC455_41297 | 10 | 0.21 | Mlig455_015247 | Neo: - Age: - |
0.985 | - | - | - | - | 0.985 | - | Mlig455_015247 {REF} {Length: 738} {NoTransDecoderORF} | |
41. | MligTC455_12203 | 8 | 0.17 | Mlig455_061049 | Neo: - Age: - |
0.983 | - | - | - | - | 0.983 | - | Mlig455_061049 {REF} {Length: 1492} {RNA1509_16662} {RNA1310_122445} {RNA815_4833.1} | |
42. | MligTC455_49214 | 6 | 0.13 | Mlig455_068565 | Neo: - Age: - |
0.982 | - | - | - | - | 0.982 | - | Mlig455_068565 {REF} {Length: 1544} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=105.5]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=53.1, Expect=3e-08]} {RNA1310_27155} {RNA815_39321} | |
43. | MligTC455_53286 | 6 | 0.13 | Mlig455_061308 | Neo: - Age: - |
0.981 | - | - | - | - | 0.981 | - | Mlig455_061308 {REF} {Length: 398} {NoTransDecoderORF} | |
44. | MligTC455_09822 | 5 | 0.1 | Mlig455_017858 | Neo: - Age: - |
0.98 | - | - | - | - | 0.980 | - | Mlig455_017858 {REF} {Length: 616} {NoTransDecoderORF} {RNA1310_73710} | |
45. | MligTC455_35325 | 26 | 0.54 | Mlig455_008452, Mlig455_031353, Mlig455_056519 | Neo: - Age: - |
HTR3A | 0.978 | - | - | - | - | 0.978 | - | Mlig455_008452 {REF} {Length: 1552} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010} Mlig455_031353 {REF} {Length: 1802} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=61.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=54.4]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=103, Expect=5e-25]; ENSG00000149305, HTR3B, 5-hydroxytryptamine receptor 3B, [Score=101, Expect=1e-24]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=100, Expect=4e-24]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=98.2, Expect=2e-23]; ENSMUSG00000008590, Htr3b, 5-hydroxytryptamine (serotonin) receptor 3B, [Score=96.3, Expect=7e-23]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=93.6, Expect=6e-22]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=100, Expect=1e-24]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=90.5, Expect=5e-21]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010} Mlig455_056519 {REF} {Length: 1867} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_53098} {RNA1310_93708} {RNA815_49010} |
46. | MligTC455_18262 | 28 | 0.59 | Mlig455_023697 | Neo: - Age: Down-Up-Down |
0.977 | - | - | - | - | 0.977 | - | Mlig455_023697 {REF} {Length: 552} {NoTransDecoderORF} {RNA1509_11101} {RNA1310_22145} {RNA815_35811} | |
47. | MligTC455_21884 | 13 | 0.27 | Mlig455_070568 | Neo: - Age: - |
SRSF7 | 0.977 | - | - | - | - | 0.977 | - | Mlig455_070568 {REF} {Length: 1659} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=59.7]; RNA recognition motif [PF16367.7, score=24.4]; Zinc knuckle [PF00098.25, score=20.7]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=19.2]} {Human: ENSG00000115875, SRSF7, serine and arginine rich splicing factor 7, [RH, Score=142, Expect=6e-43]} {Mouse: ENSMUSG00000024097, Srsf7, serine/arginine-rich splicing factor 7, [RH, Score=142, Expect=4e-43]} {Dmel: FBgn0260944, Rbp1, RNA-binding protein 1, [RH, Score=102, Expect=2e-27]} {Celegans: WBGene00004703, rsp-6, Probable splicing factor, arginine/serine-rich 6, [Score=103, Expect=7e-28]} {Smed: dd_Smed_v6_2424_0_1, dd_Smed_v6_2424_0_1, [RH, Score=124, Expect=4e-36]} {RNA1509_38744} {RNA1310_52982} {RNA815_7835} |
48. | MligTC455_42708 | 48 | 1.01 | Mlig455_027999, Mlig455_028026 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_027999 {REF} {Length: 305} {NoTransDecoderORF} {RNA1509_12495} {RNA1310_13267.2} {RNA815_40552} Mlig455_028026 {REF} {Length: 305} {NoTransDecoderORF} {RNA1509_12495} {RNA1310_13267.2} {RNA815_40552} |
|
49. | MligTC455_29464 | 25 | 0.53 | Mlig455_021892 | Neo: - Age: - |
SDCCAG8 | 0.976 | - | - | - | - | 0.976 | - | Mlig455_021892 {REF} {Length: 3036} {Pfam: Centrosomal colon cancer autoantigen protein family [PF15964.7, score=164.7]} {Human: ENSG00000276111, SDCCAG8, serologically defined colon cancer antigen 8, [RH, Score=120, Expect=2e-27]; ENSG00000054282, SDCCAG8, serologically defined colon cancer antigen 8, [RH, Score=120, Expect=2e-27]} {Mouse: ENSMUSG00000026504, Sdccag8, serologically defined colon cancer antigen 8, [RH, Score=109, Expect=4e-24]} {Dmel: FBgn0266566, CG45105, [Score=52.4, Expect=2e-06]} {Smed: dd_Smed_v6_9295_0_2, dd_Smed_v6_9295_0_2, [RH, Score=87.8, Expect=7e-18]} {RNA1509_42574} {RNA1310_5942.1} {RNA815_9353.1} |
50. | MligTC455_26562 | 51 | 1.05 | Mlig455_003821 | Neo: - Age: - Region-enriched R4: 4.788/0.04787 |
0.975 | - | - | - | - | 0.975 | - | Mlig455_003821 {REF} {Length: 3329} {NoTransDecoderORF} {RNA1509_310} {RNA1310_3669} {RNA815_20255} | |
51. | MligTC455_47574 | 716 | 14.92 | Mlig455_028318, Mlig455_066192 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=1.060 Region-enriched R2: 1.667/0.01738 |
MAN1C1 | 0.975 | - | - | - | - | 0.975 | - | Mlig455_028318 {REF} {Length: 2839} {TRANSSPLICED} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=378.3]; Glycosyl hydrolase family 76 [PF03663.16, score=19.1]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=269, Expect=4e-82]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=268, Expect=1e-81]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=268, Expect=1e-81]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=267, Expect=1e-81]; ENSMUSG00000003746, Man1a, mannosidase 1, alpha, [Score=263, Expect=2e-79]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=266, Expect=5e-81]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=249, Expect=2e-75]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=265, Expect=2e-81]} {RNA1509_9530} {RNA1310_9474.1} {RNA815_6962} Mlig455_066192 {REF} {Length: 2836} {TRANSSPLICED} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=378.3]; Glycosyl hydrolase family 76 [PF03663.16, score=19.1]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=269, Expect=4e-82]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=268, Expect=1e-81]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=268, Expect=1e-81]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=267, Expect=1e-81]; ENSMUSG00000003746, Man1a, mannosidase 1, alpha, [Score=263, Expect=2e-79]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=266, Expect=5e-81]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=249, Expect=2e-75]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=265, Expect=2e-81]} {RNA1509_53617, RNA1509_9530} {RNA1310_9474.1, RNA1509_53617} {RNA1509_53617, RNA815_6962} |
52. | MligTC455_40204 | 348 | 7.24 | Mlig455_064913, Mlig455_066843 | Neo: - Age: logFC(26M/2M)=-0.350 |
0.974 | - | - | - | - | 0.974 | - | Mlig455_064913 {REF} {Length: 1143} {NoTransDecoderORF} {RNA1509_52747} {RNA1310_89294} {RNA815_41786} Mlig455_066843 {REF} {Length: 633} {NoTransDecoderORF} {RNA1310_106751} {RNA815_41786} |
|
53. | MligTC455_10204 | 14 | 0.29 | Mlig455_049702, Mlig455_049708 | Neo: - Age: - |
0.973 | - | - | - | - | 0.973 | - | Mlig455_049702 {REF} {Length: 217} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_47324} {RNA815_43123} Mlig455_049708 {REF} {Length: 443} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_57782} {RNA815_43123} |
|
54. | MligTC455_15053 | 12 | 0.26 | Mlig455_016326 | Neo: - Age: - |
0.973 | - | - | - | - | 0.973 | - | Mlig455_016326 {REF} {Length: 2006} {NoTransDecoderORF} {RNA1509_50409, RNA1509_54815} {RNA1310_146928, RNA1509_50409} {RNA1509_50409, RNA815_32053} | |
55. | MligTC455_25410 | 47 | 0.97 | Mlig455_026185 | Neo: - Age: Up-Down-Down Region-enriched R2: 8.036/0.00469 |
0.973 | - | - | - | - | 0.973 | - | Mlig455_026185 {REF} {Length: 3002} {Pfam: Variant SH3 domain [PF07653.19, score=19.6]; Growth-arrest specific micro-tubule binding [PF13851.8, score=19.3]} {Mouse: ENSMUSG00000034156, Tspoap1, TSPO associated protein 1, [Score=54.7, Expect=6e-07]} {Smed: dd_Smed_v6_14584_0_1, dd_Smed_v6_14584_0_1, [Score=140, Expect=7e-35]} {RNA1509_45271} {RNA1310_5741} {RNA815_46868} | |
56. | MligTC455_49875 | 59 | 1.22 | Mlig455_027217 | Neo: - Age: - |
0.973 | - | - | - | - | 0.973 | - | Mlig455_027217 {REF} {Length: 1809} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.9]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=64.7, Expect=5e-12]} {Celegans: WBGene00008997, lgc-31, Ligand-Gated ion Channel, [Score=70.9, Expect=3e-14]} {Smed: dd_Smed_v6_12146_0_1, dd_Smed_v6_12146_0_1, [Score=67.0, Expect=6e-13]} {RNA1310_26175} {RNA815_7952} | |
57. | MligTC455_00072 | 10 | 0.2 | Mlig455_001911 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_001911 {REF} {Length: 296} {NoTransDecoderORF} {RNA1310_118235} | |
58. | MligTC455_31082 | 93 | 1.93 | Mlig455_020193 | Neo: - Age: Up-Down-Up |
0.972 | - | - | - | - | 0.972 | - | Mlig455_020193 {REF} {Length: 1952} {RNA1509_54750} {RNA1310_22843} {RNA815_11564.1} | |
59. | MligTC455_20571 | 72 | 1.5 | Mlig455_016577, Mlig455_035609 | Neo: - |
IRX6 | 0.969 | - | - | - | - | 0.969 | - | Mlig455_016577 {REF} {Length: 1698} {Pfam: Homeobox KN domain [PF05920.13, score=52.1]; Homeodomain [PF00046.31, score=26.8]} {Human: ENSG00000159387, IRX6, iroquois homeobox 6, [Score=127, Expect=4e-33]; ENSG00000170561, IRX2, iroquois homeobox 2, [Score=121, Expect=6e-31]} {Mouse: ENSMUSG00000031738, Irx6, Iroquois homeobox 6, [Score=123, Expect=8e-32]; ENSMUSG00000001504, Irx2, Iroquois homeobox 2, [Score=121, Expect=5e-31]; ENSMUSG00000031737, Irx5, Iroquois homeobox 5, [Score=120, Expect=1e-30]; ENSMUSG00000021604, Irx4, Iroquois homeobox 4, [Score=118, Expect=1e-29]; ENSMUSG00000031734, Irx3, Iroquois related homeobox 3, [Score=117, Expect=2e-29]} {Dmel: FBgn0015904, ara, araucan, [Score=122, Expect=7e-31]} {Celegans: WBGene00007984, irx-1, Putative iroquois-class homeodomain protein irx-1, [Score=107, Expect=1e-26]} {Smed: dd_Smed_v6_17352_0_1, dd_Smed_v6_17352_0_1, [Score=129, Expect=9e-35]} {RNA1509_32988} {RNA1310_38999} {RNA815_42442} Mlig455_035609 {REF} {Length: 3012} {Pfam: Homeobox KN domain [PF05920.13, score=52.1]; Homeodomain [PF00046.31, score=26.8]} {Human: ENSG00000159387, IRX6, iroquois homeobox 6, [Score=125, Expect=1e-32]; ENSG00000170561, IRX2, iroquois homeobox 2, [Score=120, Expect=1e-30]; ENSG00000176842, IRX5, iroquois homeobox 5, [Score=119, Expect=4e-30]} {Mouse: ENSMUSG00000031738, Irx6, Iroquois homeobox 6, [Score=122, Expect=2e-31]; ENSMUSG00000001504, Irx2, Iroquois homeobox 2, [Score=120, Expect=1e-30]; ENSMUSG00000031737, Irx5, Iroquois homeobox 5, [Score=119, Expect=3e-30]; ENSMUSG00000021604, Irx4, Iroquois homeobox 4, [Score=117, Expect=2e-29]; ENSMUSG00000031734, Irx3, Iroquois related homeobox 3, [Score=116, Expect=3e-29]} {Dmel: FBgn0015904, ara, araucan, [Score=121, Expect=1e-30]} {Celegans: WBGene00007984, irx-1, Putative iroquois-class homeodomain protein irx-1, [Score=107, Expect=2e-26]} {Smed: dd_Smed_v6_17352_0_1, dd_Smed_v6_17352_0_1, [Score=129, Expect=1e-34]} {RNA1509_32988} {RNA1310_38999} {RNA815_42442} |
60. | MligTC455_46582 | 6815 | 141.97 | Mlig455_027253, Mlig455_027264 | Neo: - Age: - Region-enriched R8: 2.137/0.00000 Regeneration-downregulated TP: -1.999 Regeneration-depleted TP: -1.999 |
0.969 | - | 0.969 | - | - | - | - | Mlig455_027253 {REF} {Length: 2256} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=25.3]} {Dmel: FBgn0051221, CG31221, [Score=63.2, Expect=5e-12]} {Celegans: WBGene00010290, F58H1.7, [RH, Score=66.6, Expect=1e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=173, Expect=3e-55]} {RNA1509_59060} {RNA1310_28256} {RNA815_15141.1} Mlig455_027264 {REF} {Length: 973} {Dmel: FBgn0051221, CG31221, [Score=53.5, Expect=1e-08]} {Celegans: WBGene00010290, F58H1.7, [Score=50.4, Expect=7e-08]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [Score=147, Expect=5e-45]} {RNA1509_59060} {RNA1310_28256} {RNA815_15141.1} |
|
61. | MligTC455_14124 | 9 | 0.19 | Mlig455_004227, Mlig455_031052, Mlig455_031059 | Neo: - |
OTOGL, SSPO | 0.968 | - | - | - | - | 0.968 | - | Mlig455_004227 {REF} {Length: 8347} {Pfam: von Willebrand factor type D domain [PF00094.27, score=218.9]; C8 domain [PF08742.13, score=94.5]; Low-density lipoprotein receptor domain class A [PF00057.20, score=62.7]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=52.1]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=506, Expect=2e-143]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=499, Expect=2e-141]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=327, Expect=5e-89]} {Celegans: WBGene00020481, T13C2.6, [Score=107, Expect=5e-23]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1126, Expect=0.0]} {RNA1509_11979, RNA1509_44751} {RNA1310_598, RNA1509_44751} {RNA1509_44751, RNA815_582} Mlig455_031052 {REF} {Length: 3393} {Pfam: von Willebrand factor type D domain [PF00094.27, score=117.0]; C8 domain [PF08742.13, score=60.4]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.8]} {Human: ENSG00000165899, OTOGL, otogelin like, [Score=200, Expect=1e-51]} {Mouse: ENSMUSG00000001930, Vwf, Von Willebrand factor, [Score=200, Expect=8e-52]; ENSMUSG00000091455, Otogl, otogelin-like, [Score=196, Expect=1e-50]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=149, Expect=4e-36]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=497, Expect=7e-154]} {RNA1509_47011} {RNA1310_598} {RNA815_582} Mlig455_031059 {REF} {Length: 5292} {Pfam: von Willebrand factor type D domain [PF00094.27, score=221.4]; C8 domain [PF08742.13, score=99.8]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=55.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=52.2]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=489, Expect=4e-142]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=488, Expect=6e-142]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=322, Expect=1e-88]} {Celegans: WBGene00003071, lrp-1, Low-density lipoprotein receptor-related protein, [Score=74.7, Expect=6e-13]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1061, Expect=0.0]} {RNA1509_47011} {RNA1310_598} {RNA815_582} |
62. | MligTC455_21405 | 54 | 1.13 | Mlig455_047017, Mlig455_052380 | Neo: - Age: - Region-enriched R4: 5.038/0.00957 |
0.968 | - | - | - | - | - | 0.968 | Mlig455_047017 {REF} {Length: 2240} {RNA1310_30090} {RNA815_47725} Mlig455_052380 {REF} {Length: 1329} {RNA1509_49721} {RNA1310_33296} {RNA815_49583} |
|
63. | MligTC455_33875 | 32 | 0.67 | Mlig455_039631 | Neo: - Age: - |
0.968 | - | - | - | - | 0.968 | - | Mlig455_039631 {REF} {Length: 3055} {TRANSSPLICED} {RNA1509_14655, RNA1509_53977} {RNA1310_22046.1, RNA1509_53977} {RNA1509_53977, RNA815_8738} | |
64. | MligTC455_15005 | 13 | 0.26 | Mlig455_007503 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_007503 {REF} {Length: 2488} {Pfam: Immunoglobulin domain [PF13895.8, score=20.5]} {RNA1310_66411} {RNA815_43821} | |
65. | MligTC455_24786 | 300 | 6.25 | Mlig455_032143, Mlig455_049302 | Neo: - Age: logFC(26M/2M)=-0.528 |
0.966 | - | - | - | - | 0.966 | - | Mlig455_032143 {REF} {Length: 358} {NoTransDecoderORF} {RNA1509_36687} {RNA1310_1894} {RNA815_5614.1} Mlig455_049302 {REF} {Length: 3378} {Pfam: PT repeat [PF04886.14, score=51.8]} {RNA1509_45844} {RNA1310_12902.2} {RNA815_515.1} |
|
66. | MligTC455_32222 | 6 | 0.13 | Mlig455_068777 | Neo: - Age: Down-Up-Down |
0.966 | - | - | - | - | 0.966 | - | Mlig455_068777 {REF} {Length: 1563} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=38.2]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=55.5, Expect=1e-08]} {RNA1509_41917} {RNA1310_24082} {RNA815_13028} | |
67. | MligTC455_51123 | 37 | 0.77 | Mlig455_059507 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_059507 {REF} {Length: 970} {RNA1310_88282} | |
68. | MligTC455_42103 | 19 | 0.4 | Mlig455_013890 | Neo: - Age: - |
ARID3A | 0.964 | - | - | - | - | 0.964 | - | Mlig455_013890 {REF} {Length: 2772} {Pfam: ARID/BRIGHT DNA binding domain [PF01388.23, score=72.2]} {Human: ENSG00000116017, ARID3A, AT-rich interaction domain 3A, [RH, Score=244, Expect=2e-71]; ENSG00000205143, ARID3C, AT-rich interaction domain 3C, [RH, Score=242, Expect=1e-72]; ENSG00000179361, ARID3B, AT-rich interaction domain 3B, [RH, Score=233, Expect=8e-68]} {Mouse: ENSMUSG00000019564, Arid3a, AT rich interactive domain 3A (BRIGHT-like), [RH, Score=247, Expect=9e-73]; ENSMUSG00000066224, Arid3c, AT rich interactive domain 3C (BRIGHT-like), [RH, Score=245, Expect=2e-74]} {Dmel: FBgn0004795, retn, retained, [RH, Score=241, Expect=2e-68]} {Celegans: WBGene00000476, cfi-1, AT-rich interactive domain-containing protein cfi-1, [RH, Score=231, Expect=3e-68]} {Smed: dd_Smed_v6_13474_0_1, dd_Smed_v6_13474_0_1, [RH, Score=259, Expect=1e-77]} {RNA1509_54880} {RNA1310_44805} {RNA815_49768} |
69. | MligTC455_30826 | 98 | 2.04 | Mlig455_047664 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_047664 {REF} {Length: 879} {NoTransDecoderORF} {RNA1310_39208} {RNA815_16462} | |
70. | MligTC455_24422 | 159 | 3.31 | Mlig455_014156 | Neo: - Age: - |
TANC2 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_014156 {REF} {Length: 4949} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=57.6]; Ankyrin repeats (many copies) [PF13637.8, score=49.0]; Mab-21 protein [PF03281.16, score=44.5]; Ankyrin repeat [PF13606.8, score=39.6]; Ankyrin repeat [PF00023.32, score=35.4]; Ankyrin repeats (many copies) [PF13857.8, score=31.6]} {Human: ENSG00000170921, TANC2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=72.0, Expect=6e-12]} {Mouse: ENSMUSG00000078487, Ankrd65, ankyrin repeat domain 65, [Score=72.8, Expect=6e-13]; ENSMUSG00000053580, Tanc2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=72.0, Expect=4e-12]} {Dmel: FBgn0041096, rols, rolling pebbles, [Score=68.2, Expect=4e-11]} {Celegans: WBGene00007252, mlt-2, [Score=63.2, Expect=8e-10]} {Smed: dd_Smed_v6_21003_0_1, dd_Smed_v6_21003_0_1, [Score=62.0, Expect=2e-09]} {RNA1509_17002} {RNA1310_2398} {RNA815_4370} |
71. | MligTC455_56572 | 7 | 0.15 | Mlig455_055432 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_055432 {REF} {Length: 280} {NoTransDecoderORF} {RNA1509_59493} {RNA1310_14118} {RNA815_4477.2} | |
72. | MligTC455_01255 | 21 | 0.44 | Mlig455_030146 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_030146 {REF} {Length: 843} {NoTransDecoderORF} {RNA1509_20101} {RNA1310_14959.1} {RNA815_22311} | |
73. | MligTC455_23938 | 109 | 2.26 | Mlig455_044682 | Neo: - Age: logFC(26M/2M)=0.355 |
TRPM3 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_044682 {REF} {Length: 6333} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=80.4]; Ankyrin repeats (3 copies) [PF12796.9, score=74.8]; Ankyrin repeat [PF13606.8, score=59.5]; Ion transport protein [PF00520.33, score=57.5]; Ankyrin repeat [PF00023.32, score=51.1]; Ankyrin repeats (many copies) [PF13857.8, score=38.9]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=139, Expect=2e-32]; ENSG00000134160, TRPM1, transient receptor potential cation channel subfamily M member 1, [Score=139, Expect=2e-32]; ENSG00000274965, TRPM1, transient receptor potential cation channel subfamily M member 1, [Score=139, Expect=2e-32]} {Mouse: ENSMUSG00000030523, Trpm1, transient receptor potential cation channel, subfamily M, member 1, [Score=141, Expect=3e-33]; ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=140, Expect=4e-33]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=112, Expect=2e-24]} {Celegans: WBGene00001651, gon-2, Transient receptor potential channel, [Score=111, Expect=2e-24]} {Smed: dd_Smed_v6_8382_0_1, dd_Smed_v6_8382_0_1, [Score=192, Expect=2e-49]} {RNA1509_19611, RNA1509_32799} {RNA1310_1742.1, RNA1509_19611, RNA1509_32799} {RNA1509_19611, RNA1509_32799, RNA815_1771} |
74. | MligTC455_42489 | 236 | 4.91 | Mlig455_046431 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.696 Region-enriched R2: 2.739/0.01786 |
0.952 | - | - | - | - | 0.952 | - | Mlig455_046431 {REF} {Length: 2159} {Smed: dd_Smed_v6_12856_0_1, dd_Smed_v6_12856_0_1, [RH, Score=107, Expect=3e-27]} {RNA1509_6433} {RNA1310_24046, RNA1509_6433} {RNA1509_6433, RNA815_8453} | |
75. | MligTC455_52462 | 166 | 3.45 | Mlig455_005943 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=4.076 Regeneration-upregulated R2: 5.759 Regeneration-enriched R2: 5.759 |
AGRN | 0.952 | - | - | - | - | 0.952 | - | Mlig455_005943 {REF} {Length: 1577} {Pfam: Kazal-type serine protease inhibitor domain [PF00050.23, score=130.4]; Kazal-type serine protease inhibitor domain [PF07648.17, score=91.6]} {Human: ENSG00000188157, AGRN, agrin, [Score=55.8, Expect=8e-08]} {Mouse: ENSMUSG00000041936, Agrn, agrin, [Score=56.2, Expect=4e-08]} {Dmel: FBgn0052354, CG32354, [Score=48.1, Expect=9e-06]} {Smed: dd_Smed_v6_3649_0_1, dd_Smed_v6_3649_0_1, [Score=51.6, Expect=5e-07]} {RNA1509_43736} {RNA1310_19594} {RNA815_11515} |
76. | MligTC455_06009 | 10 | 0.21 | Mlig455_029013 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_029013 {REF} {Length: 278} {NoTransDecoderORF} {RNA1509_52207} {RNA1310_104907} {RNA815_61228} | |
77. | MligTC455_10303 | 18 | 0.37 | Mlig455_046266, Mlig455_061552 | Neo: - Age: Up-Down-Down |
0.951 | - | - | - | - | 0.951 | - | Mlig455_046266 {REF} {Length: 471} {NoTransDecoderORF} {RNA1509_39059} {RNA1310_16810} {RNA815_14408} Mlig455_061552 {REF} {Length: 293} {NoTransDecoderORF} {RNA1509_39059} {RNA1310_16810} {RNA815_14408} |
|
78. | MligTC455_17534 | 40 | 0.84 | Mlig455_004568 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.609/0.04169 |
0.951 | - | - | - | - | 0.951 | - | Mlig455_004568 {REF} {Length: 2000} {Pfam: CD20-like family [PF04103.17, score=25.6]} {RNA1509_45188} {RNA1310_19605, RNA1509_45188} {RNA1509_45188, RNA815_13393} | |
79. | MligTC455_27373 | 67 | 1.41 | Mlig455_052992 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_052992 {REF} {Length: 5084} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=29.1]; Mab-21 protein [PF03281.16, score=24.9]; Ankyrin repeat [PF13606.8, score=21.1]; Ankyrin repeats (many copies) [PF13857.8, score=19.7]} {Smed: dd_Smed_v6_8675_0_1, dd_Smed_v6_8675_0_1, [Score=51.2, Expect=2e-06]} {RNA1509_49840} {RNA1310_34807} {RNA815_2400.1} | |
80. | MligTC455_52065 | 35 | 0.73 | Mlig455_043270, Mlig455_043296 | Neo: Int S/G2/M Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_043270 {REF} {Length: 1377} {NoTransDecoderORF} {RNA1310_78448} Mlig455_043296 {REF} {Length: 1020} {NoTransDecoderORF} {RNA1310_78448} |